Asthma treatment step

INTRODUCTION

As a pharmacist I am concerned with the number of patients with persistent asthma treated only with a short-acting bronchodilators such as salbutamol. This could, for many patients mild intermittent asthma can reach this persistent form of the disease with better disease control with long-acting drugs, particularly for drugs with anti-inflammatory effect of inhaled corticosteroids. We must get rid once and forquite misleading to think: no = no wheezing illness, which has yet to find many supporters.

STEP THERAPY

The treatment of asthma may be initiated either as a step to gain control after gain control or get off too quickly. I have not yet scientific studies that directly compared the two techniques, the step-down therapy is the method I preferred for a number of reasons. The main reason I like the step-down plan is to make inspections to ensure thatobtained earlier. Another advantage is that is the question whether a higher dose, even more useful features at the same time, yet allow the patient to put an end to end until the lowest dose of responses for sustainable control.

Get into therapy is to show the treatment to a higher level than the current level of symptoms and tests. For example, a patient is symptomatic or twice a week, but usually less than once a day and nighttime symptoms about twiceMonth usually staged as mild persistent. With the patient will step down therapy, treatment with the highest level (moderate persistent) top. If the control is achieved after an initial period of one month or so, then therapy could be gradually reduced to a lower level (mild persistent). Because of the many variables involved, such as unknown causes and the lack of confidence about how quickly the patient can deteriorate, many doctors prefer to remain at the highest level for a couple of months to beensure that the long-term control was achieved. The controller may, on parameters such as acceptable to use the peak values of flux and change, limited need for a rescue inhaler and elimination of nighttime symptoms. Certainly, a patient, not the obvious control check after a month or so, further evaluation of any schedule changes or additional tests for diagnosis.

If the decision to launch a step down, it is important, then graduallynot to lose control already achieved. When an inhaled corticosteroid, it is often necessary to decrease at a rate of 25% every few months to the lowest dose needed to maintain control. If the patient ends up with the lowest dose of a particular product, your doctor may consider to see much less potent inhaled corticosteroid, if possible further reduction. It must, if the patient really so persistent asthma, and not just a mild intermittent observed with aggravation,therefore it is unlikely that the arrest of inhaled corticosteroid is a good idea. The majority of patients continue to benefit if the persistent anti-inflammatory corticosteroids continued at a low dose. If drugs such as additional controllers salmeterol had a decision will be used to prevent them might make more sense. I know of at least one study showing that patients on salmeterol may have a reduced response to salbutamol, if you need to have an emergency situation to appear. Therefore, a well-controlledpersistent asthma may be treated at best with only a low dose of inhaled corticosteroids with minimal need for medication and then with a rapid-acting beta-agonists such as salbutamol added.

CONCLUSSION

Step-down therapy for asthma is a logical, results, technology, enables rapid control of still allowed a gradual reduction of medication at the lowest level necessary to maintain long-term control.

Althoughthe most current and accurate as possible, the information and opinions expressed in this article or you belong to the author by e-mail or otherwise, can not be on your health and should not be used as the basis for the diagnosis or direct treat a particular disease. Always consult your doctor before you plan to make changes to the treatment.